Editor's Choice for June 2016
29 Jun 2016
Editor's Choice for June 2016
Editor's ASCO 2016 Roundup
Novel therapies for older patients with AML and MDS
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo
SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML
Improved survival in adult ALL
Multiple myeloma highlights from EHA 2016
An overview of MCL from EHA 2016
Checkpoint inhibitor therapy benefits advanced bladder cancer patients
Daratumumab slows progression in refractory multiple myeloma
Recent developments in targeted therapies
MyPathway guidance of targeted therapy based on molecular profiles